The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 14th 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
Data Supports Long-Term Efficacy for Opioid Therapy for Chronic Non-Cancer Pain
May 10th 2013A review of randomized controlled trials and open-label studies of 6 months or longer finds good evidence that opioid therapy improves pain scores, with weaker evidence for its long-term effect on functional status.
Read More
Study Finds Only Half of Patients Receive Recommended Initial Dose of Butrans
May 10th 2013Analysis of claims data finds patients often receive starting doses of Butrans (buprenorphine) that do not follow published recommendations, with more than one-third of patients receiving initial doses that are too low.
Read More
Court Case Questions REMS Restrictions
April 24th 2013The FDA's restricted distribution programs, intended for medications with toxicity risks or other potential dangers, may also be used to impede biosimilar competition, according to a Federal Trade Commission amicus brief filed in the US District Court for the District of New Jersey.
Read More